Electromed (ELMD) Cash from Financing Activities (2010 - 2026)
Electromed's (ELMD) quarterly Cash from Financing Activities came in at $694000.0 in Q2 2026, up 119.0% year-over-year from $316890.2 in Q2 2025, and up 642.19% quarter-over-quarter from -$128000.0 in Q1 2026.
Powered by 
Analysis
Electromed (ELMD) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Electromed (ELMD) has reported Cash from Financing Activities for 17 consecutive years, with $694000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Financing Activities rose 119.0% year-over-year to $694000.0 in Q2 2026; TTM through Jun 2026 was -$3.2 million, a 73.05% increase from a year earlier, with the FY2026 full-year figure at -$3.2 million, up 73.05% from the prior year.
- Cash from Financing Activities was $694000.0 for Q2 2026 at Electromed, up from -$128000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $694000.0 in Q2 2026 and troughed at -$4.5 million in Q3 2024.
- A 5-year average of -$901000.0 and a median of -$213000.0 in 2022 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities surged 225.0% in 2023 and slumped 15503.45% in 2024, its largest moves.
- Over 5 years, Cash from Financing Activities stood at $8000.0 in 2022, then surged by 225.0% to $26000.0 in 2023, then tumbled by 2188.46% to -$543000.0 in 2024, then sank by 395.76% to -$2.7 million in 2025, then surged by 125.78% to $694000.0 in 2026.
- The last three Cash from Financing Activities figures came in at $694000.0 (Q2 2026), -$128000.0 (Q1 2026), and -$2.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Electromed | 222.94 Mn | 202.49 Mn | 15.28 Mn | 694,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 694,000.00 |
| Mar 31, 2026 | -128,000.00 |
| Dec 31, 2025 | -2.69 Mn |
| Sep 30, 2025 | -1.08 Mn |
| Jun 30, 2025 | -3.65 Mn |
| Mar 31, 2025 | -3.22 Mn |
| Dec 31, 2024 | -543,000.00 |
| Sep 30, 2024 | -4.47 Mn |
| Jun 30, 2024 | -75,000.00 |
| Mar 31, 2024 | 56,000.00 |
| Dec 31, 2023 | 26,000.00 |
| Sep 30, 2023 | 29,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | -221,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Sep 30, 2022 | -205,000.00 |
| Jun 30, 2022 | -493,000.00 |
| Mar 31, 2022 | -299,000.00 |
| Dec 31, 2021 | -670,000.00 |
| Sep 30, 2021 | -63,000.00 |